Sign in

CIK 0001595248

  • Non-accelerated filer
  • Smaller reporting company

Genprex, Inc.

Sign in to watch
Ticker
GNPX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TX
Entity type
Operating
EIN
900772347
Phone
+1 512-537-7997
Business address
3300 BEE CAVE ROAD SUITE 650-227, AUSTIN, TX, 78746
  1. 4 Grant or award Director acquired 123,795 shares (grant or award)
  2. 4 Grant or award Director acquired 123,795 shares (grant or award)
  3. 4 Grant or award Director acquired 123,795 shares (grant or award)
  4. 4 Open-market buy Chairman, President and CEO bought 19,000 shares at $1.06 ($20,045)
  5. 4 Open-market buy EVP GC Chief Strategy Officer bought 20,000 shares at $1.07 ($21,478)
  6. 4 Grant or award EVP GC Chief Strategy Officer acquired 245,000 shares (grant or award)
  7. 4 Grant or award Chief Medical Officer acquired 245,000 shares (grant or award)
  8. 4 Grant or award Chief Mfgr & Tech Officer acquired 200,000 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 245,000 shares (grant or award)
  10. 4 Grant or award President & CEO acquired 625,000 shares (grant or award)
  11. 4 Exercise or conversion Chief Financial Officer acquired 116,973 shares (option exercise)
  12. 3/A Insider 3/A
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 5 Insider Annual Insider Trading Report
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 5 · 99 filings